Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

Core Insights - Sensus Healthcare is expected to report a year-over-year increase in earnings driven by higher revenues, with a consensus EPS estimate of $0.03 per share, reflecting a 250% increase compared to the previous year [9][11]. - The company is projected to achieve revenues of $7 million, which is a 54.5% increase from the same quarter last year [12]. - Analysts have recently become more optimistic about Sensus Healthcare's earnings prospects, resulting in an Earnings ESP of +20%, indicating a strong likelihood of beating the consensus EPS estimate [3][4]. Earnings Performance - Over the last four quarters, Sensus Healthcare has beaten consensus EPS estimates three times, showcasing a positive surprise history [6][15]. - In the last reported quarter, the company was expected to post a loss of $0.04 per share but instead delivered earnings of $0.14, resulting in a surprise of +450% [15]. Industry Context - In contrast, Waters (WAT), another player in the medical instruments industry, is expected to report earnings of $2.55 per share for the same quarter, indicating a year-over-year decline of 8.9%, with revenues projected at $698 million, down 5.8% from the previous year [25]. - Waters currently has a negative Earnings ESP of -0.57% and a Zacks Rank of 4 (Sell), making it difficult to predict a beat on the consensus EPS estimate [7][26]. Analyst Insights - The Zacks Earnings ESP model suggests that a positive Earnings ESP, particularly when combined with a strong Zacks Rank, significantly increases the likelihood of an earnings beat [22]. - Sensus Healthcare holds a Zacks Rank of 2 (Buy), enhancing its potential as a compelling earnings-beat candidate [23]. Conclusion - The upcoming earnings report for Sensus Healthcare is anticipated to positively impact its stock price if the results exceed expectations, while the performance of Waters may lead to a decline if it fails to meet its estimates [18].